Tazeen Ahmad Score: 29
Analyst at
Bank of America Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+16.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
53%
9 W / 8 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
64%
7 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 11 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
55%
6 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
56%
9 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 29, 2024 |
Incyte Corp.
INCY
|
BUY |
$90.00
Est. +22%
|
$73.60 | $94.42 |
Target Met
|
$108.53
+47.5%
|
| Oct 17, 2024 |
Amicus Therapeutics Inc
FOLD
|
BUY |
$15.00
Est. +25%
|
$12.03 | $12.65 |
Miss
|
$14.49
+20.4%
|
| Oct 11, 2024 |
Sutro Biopharma Inc
STRO
|
BUY |
$12.00
Est. +232%
|
$3.61 | $46.00 |
Target Met
|
$28.80
+697.8%
|
| Sep 27, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$307.00
Est. +12%
|
$274.91 | $484.21 |
Target Met
|
$282.85
+2.9%
|
| Sep 23, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$191.00
Est. +26%
|
$151.26 | $208.16 |
Target Met
|
$218.06
+44.2%
|
| Sep 16, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$175.00
Est. +23%
|
$142.26 | $208.16 |
Target Met
|
$218.06
+53.3%
|
| Sep 16, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$150.00
Est. +22%
|
$123.40 | $131.49 |
Miss
|
$90.54
-26.6%
|
| Sep 16, 2024 |
Incyte Corp.
INCY
|
BUY |
$68.00
Est. +7%
|
$63.56 | $87.99 |
Target Met
|
$108.53
+70.8%
|
| Sep 12, 2024 |
Fulcrum Therapeutics Inc
FULC
|
SELL |
$2.00
Est. +42%
|
$3.44 | $2.32 (Low) |
Miss
|
$3.45
-0.3%
|
| Sep 09, 2024 |
Fulcrum Therapeutics Inc
FULC
|
BUY |
$10.00
Est. +16%
|
$8.61 | $9.30 |
Miss
|
$3.45
-59.9%
|
| Sep 04, 2024 |
Denali Therapeutics Inc
DNLI
|
BUY |
$29.00
Est. +15%
|
$25.12 | $33.32 |
Target Met
|
$21.66
-13.8%
|
| Mar 20, 2022 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$161.00
Est. +37%
|
$117.44 | - | - |
$218.06
+85.7%
|
| Mar 01, 2022 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$31.00
Est. +24%
|
$25.07 | - | - |
$21.09
-15.9%
|
| Jan 26, 2022 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$127.00
Est. +68%
|
$75.51 | - | - |
$159.76
+111.6%
|
| Jan 26, 2022 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$209.00
Est. +61%
|
$130.12 | - | - |
$282.85
+117.4%
|
| Dec 20, 2021 |
Argen X SE - ADR
ARGX
|
BUY |
$383.00
Est. +13%
|
$337.51 | - | - |
$893.52
+164.7%
|
| Sep 09, 2021 |
Arvinas Inc
ARVN
|
BUY |
$110.00
Est. +16%
|
$95.07 | - | - |
$7.58
-92.0%
|
Incyte Corp.
INCY
Oct 29, 2024
Signal & Target
BUY
$90.00
Start Price
$73.60
Best Price (1Y)
$94.42
Current Price
$108.53
Return
+47.5%
Amicus Therapeutics Inc
FOLD
Oct 17, 2024
Signal & Target
BUY
$15.00
Start Price
$12.03
Best Price (1Y)
$12.65
Current Price
$14.49
Return
+20.4%
Sutro Biopharma Inc
STRO
Oct 11, 2024
Signal & Target
BUY
$12.00
Start Price
$3.61
Best Price (1Y)
$46.00
Current Price
$28.80
Return
+697.8%
Alnylam Pharmaceuticals Inc
ALNY
Sep 27, 2024
Signal & Target
BUY
$307.00
Start Price
$274.91
Best Price (1Y)
$484.21
Current Price
$282.85
Return
+2.9%
Ascendis Pharma A/S - ADR
ASND
Sep 23, 2024
Signal & Target
BUY
$191.00
Start Price
$151.26
Best Price (1Y)
$208.16
Current Price
$218.06
Return
+44.2%
Ascendis Pharma A/S - ADR
ASND
Sep 16, 2024
Signal & Target
BUY
$175.00
Start Price
$142.26
Best Price (1Y)
$208.16
Current Price
$218.06
Return
+53.3%
BioNTech SE - ADR
BNTX
Sep 16, 2024
Signal & Target
BUY
$150.00
Start Price
$123.40
Best Price (1Y)
$131.49
Current Price
$90.54
Return
-26.6%
Incyte Corp.
INCY
Sep 16, 2024
Signal & Target
BUY
$68.00
Start Price
$63.56
Best Price (1Y)
$87.99
Current Price
$108.53
Return
+70.8%
Fulcrum Therapeutics Inc
FULC
Sep 12, 2024
Signal & Target
SELL
$2.00
Start Price
$3.44
Best Price (1Y)
$2.32
Current Price
$3.45
Return
-0.3%
Fulcrum Therapeutics Inc
FULC
Sep 09, 2024
Signal & Target
BUY
$10.00
Start Price
$8.61
Best Price (1Y)
$9.30
Current Price
$3.45
Return
-59.9%
Denali Therapeutics Inc
DNLI
Sep 04, 2024
Signal & Target
BUY
$29.00
Start Price
$25.12
Best Price (1Y)
$33.32
Current Price
$21.66
Return
-13.8%
Ascendis Pharma A/S - ADR
ASND
Mar 20, 2022
Signal & Target
BUY
$161.00
Start Price
$117.44
Best Price (1Y)
-
Current Price
$218.06
Return
+85.7%
Acadia Pharmaceuticals Inc
ACAD
Mar 01, 2022
Signal & Target
BUY
$31.00
Start Price
$25.07
Best Price (1Y)
-
Current Price
$21.09
Return
-15.9%
Neurocrine Biosciences, Inc.
NBIX
Jan 26, 2022
Signal & Target
BUY
$127.00
Start Price
$75.51
Best Price (1Y)
-
Current Price
$159.76
Return
+111.6%
Alnylam Pharmaceuticals Inc
ALNY
Jan 26, 2022
Signal & Target
BUY
$209.00
Start Price
$130.12
Best Price (1Y)
-
Current Price
$282.85
Return
+117.4%
Argen X SE - ADR
ARGX
Dec 20, 2021
Signal & Target
BUY
$383.00
Start Price
$337.51
Best Price (1Y)
-
Current Price
$893.52
Return
+164.7%
Arvinas Inc
ARVN
Sep 09, 2021
Signal & Target
BUY
$110.00
Start Price
$95.07
Best Price (1Y)
-
Current Price
$7.58
Return
-92.0%